SUZHOU, China I June 24, 2025 I BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...

SUZHOU, China, June 23, 2025 /CNW/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...

Scientists with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States, and a leading research center for diabetes and other life ...

This 12oz ribeye doesn’t just sit on the plate—it commands attention with its perfect char and juicy interior, flanked by rice pilaf and broccoli for those with a conscience. Photo credit: Jarett D.

Currently, fewer than half of patients with type 2 diabetes achieve optimal glycemic control on current incretin therapies. Cardioprotective effects in HFpEF - Dr. Yan's poster will show that in a ...

Specifically, the study reported elevated blood sugar levels and increased insulin in participants – both early indicators of type 2 diabetes. The study also found that certain varieties of low or ...

In this Phase 2b clinical trial (NCT06256549), a total of 272 eligible Chinese patients with T2DM, who had inadequate glycemic control either after lifestyle intervention or despite stable use of ...

Type 2 diabetes diagnosed in childhood or early adulthood is termed early-onset type 2 diabetes. Cases of early-onset type 2 diabetes are increasing rapidly globally, alongside rising obesity.